Story preview
Topics in this story
Continue reading on the publisher site for the full article.
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
4
in the last 3 days
First reported
10 days ago
3 outlets since
Countries
3 other outlets reported this story in the last 3 days.
On October 9, 2023, Wells Fargo maintained an Equal-Weight rating for Amgen (AMGN) while adjusting its price target down from $435 to $430, reflecting a -1.15%
Stokes Capital Advisors LLC raised its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 187.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,811 shares of the medical research company